Shilpa Medicare soars on receiving EIR for Telangana facility

09 Oct 2017 Evaluate

Shilpa Medicare is currently trading at Rs. 653.00, up by 27.05 points or 4.32% from its previous closing of Rs. 625.95 on the BSE.

The scrip opened at Rs. 651.40 and has touched a high and low of Rs. 658.00 and Rs. 644.70 respectively. So far 6014 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 786.75 on 21-Dec-2016 and a 52 week low of Rs. 525.00 on 09-Nov-2016.

Last one week high and low of the scrip stood at Rs. 658.00 and Rs. 570.00 respectively. The current market cap of the company is Rs. 5208.25 crore.

The promoters holding in the company stood at 54.74%, while Institutions and Non-Institutions held 31.89% and 13.37% respectively.

Shilpa Medicare has received Establishment Inspection Report (EIR) from the United States Food & Drug Administration (USFDA) for its generic pharmaceutical manufacturing facility at Jadcherla in Telangana, India which was inspected between July 24 and July 28 2017.

The inspection has now been closed by the USFDA. The company had submitted a detailed corrective and preventive action (CAPA) plan to the regulator within the stipulated timelines in response to the form 483 issued at the end of inspection. The USFDA has reviewed the CAPA and has found them acceptable.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.3

Shilpa Medicare Share Price

323.60 -7.70 (-2.32%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×